title: Specific antioxidant activity of caffeoyl derivatives and other natural phenolic compounds: LDL protection against oxidation and decrease in the proinflammatory lysophosphatidylcholine production.
abstract: Specific antioxidant activity (SAA) (i.e., activity related to the molar or gallic acid equivalent amount of antioxidant) of natural polyphenolic mixtures or pure phenolic compounds was studied using their capacity to delay the conjugated diene production brought about by in vitro LDL copper-mediated or AAPH-mediated oxidation. The cinnamic acid series (caffeic, sinapic, ferulic acids) displayed a constant SAA over a large range of concentrations, whereas the benzoic acid series (gallic and protocatechuic acids) showed much higher SAA at low concentrations. The natural phenolic mixtures had a constant SAA. The highest SAA was obtained with caffeoyl esters (caffeoylquinic, rosmarinic, and caffeoyltartaric acids) and catechin for the copper-oxidation and the AAPH-oxidation system, respectively. Phenolic mixtures and acids delayed vitamin E depletion and decreased proinflammatory lysophosphatidylcholine production. As with polyphenols, probucol delayed lysophosphatidylcholine and conjugated dienes production, at higher concentrations, but was not effective at preventing vitamin E depletion. Polyphenols prevent the oxidation of LDL and its constituents (vitamin E, phosphatidylcholine), which is compatible with an antiinflammatory and antiatherosclerotic role in pathophysiological conditions.
authors.affiliation: Laboratoire de Nutrition Humaine et Athérogenese, UPRES-EA 2993, Faculté de Médecine, Université de Montpellier I, F-34060, France.
authors.forename: E
authors.initials: E
authors.lastname: Cartron
authors.forename: M A
authors.initials: MA
authors.lastname: Carbonneau
authors.forename: G
authors.initials: G
authors.lastname: Fouret
authors.forename: B
authors.initials: B
authors.lastname: Descomps
authors.forename: C L
authors.initials: CL
authors.lastname: Léger
mesh_terms: D000975:Antioxidants / Q000494:pharmacology*; D002109:Caffeic Acids / Q000494:pharmacology*; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D008077:Lipoproteins, LDL / Q000097:blood; D008244:Lysophosphatidylcholines / Q000096:biosynthesis*; D010084:Oxidation-Reduction; D010636:Phenols / Q000494:pharmacology*
chemical_list: D000975:Antioxidants; D002109:Caffeic Acids; D018836:Inflammation Mediators; D008077:Lipoproteins, LDL; D008244:Lysophosphatidylcholines; D010636:Phenols; C040048:caffeic acid